Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH

Human Reproduction

Volumn 21, Issue 1, 2006, Pages 171-174

  Abdalla, H ^a   Thum, M Y ^a  

^a LISTER HOSPITAL   (United Kingdom)

Author keywords

Basal stimulating hormone; FSH; IVF outcome; Pregnancy rate

Indexed keywords

FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MENSTRUAL CYCLE; OOCYTE; PATIENT SELECTION; PREGNANCY RATE; PROGNOSIS; REPRODUCTIVE SUCCESS;

EID: 29144475861     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei288     Document Type: Article

References (16)

1. Abdalla H and Thum MY (2004) An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 19,893-898.
2. Agrawal R, Holmes J and Jacobs HS (2000) Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: A meta-analysis. Fertil Steril 73,338-343.
3. Bancsi LF, Huijs AM, den Ouden CT, Broekmans FJ, Looman CW, Blankenstein MA and te Velde ER (2000) Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril 73,552-557.
4. Bancsi LF, Broekmans FJ, Looman CW, Habbema JD and te Velde ER (2004) Predicting poor ovarian response in IVF: Use of repeat basal FSH measurement. J Reprod Med 49,187-194.
5. Borm G and Mannaerts B (2000) Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 15,1490-1498. Erratum in: Hum Reprod 15(8),1877.
6. Creus M, Penarrubia J, Farbregues F et al (2000) Day 3 serum inhibin and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15,2341-2346.
7. El-Toukhy T, Khalaf Y, Hart R, Taylor A and Braude P (2002) Young age does not protect against the adverse effects of reduced ovarian reserve - an eight year study. Hum Reprod 17,1519-1524.
8. Frattarelli JL, Lauria-Costab DF, Miller BT, Bergh PA and Scott RT (2000) Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril 74,512-517.
9. Lass A, Gerrard A, Abusheikha N, Akagbosu F and Brinsden P (2000) IVF performance of women who have fluctuating early follicular FSH levels. J Assist Reprod Genet 17,566-573.
10. Mohamed KA, Davies WA, Allsopp J and Lashen H (2005) Agonist "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 83,331-335.
11. Scott RT Jr and Hofmann GE (1995) Prognostic assessment of ovarian reserve. Fertil Steril 63,1-11.
12. Scott RT, Tonner JP, Muasher SJ et al (1989) Follicle stimulating levels on cycle day 3 are predictive of in vitro fertilisation outcome. Fertil Steril 51,651-654.
13. Scott RT Jr, Hofmann GE, Oehinger S and Muasher SJ (1990) Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilisation. Fertil Steril 54,297-302.
14. Sharif K and Afnan M (2003) The IVF league tables: Time for a reality check. Hum Reprod 18,483-485.
15. Sharif K, Elgendy M, Lashen H and Afnan M (1998) Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol 105,107.
16. Van Wely M, Westergaard LG, Bossuyt PM and Van der Veen F (2003) Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev (1):CD003973. Review.